Eusebi Chiner Vives-rekin lankidetzan egindako argitalpenak (21)

2023

  1. Proteomic profiling for prediction of recurrent cardiovascular event in patients with acute coronary syndrome and obstructive sleep apnea: A post-hoc analysis from the ISAACC study

    Biomedicine and Pharmacotherapy, Vol. 158

2022

  1. Effectiveness of CPAP vs. Noninvasive Ventilation Based on Disease Severity in Obesity Hypoventilation Syndrome and Concomitant Severe Obstructive Sleep Apnea

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 228-236

  2. Long-Term Effect of Obstructive Sleep Apnea and Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients with Acute Coronary Syndrome: A Clinical Trial

    Annals of the American Thoracic Society, Vol. 19, Núm. 10, pp. 1750-1759

  3. Respiratory Polygraphy Patterns and Risk of Recurrent Cardiovascular Events in Patients With Acute Coronary Syndrome

    Frontiers in Medicine, Vol. 9

  4. Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, Vol. 18, Núm. 4, pp. 983-992

  5. [Translated article] International consensus document on obstructive sleep apnea

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. T52-T68

2021

  1. International Consensus Document on Obstructive Sleep Apnea

    Archivos de Bronconeumologia

2020

  1. Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea

    Thorax, Vol. 75, Núm. 6, pp. 459-467

  2. Echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome long-term pickwick randomized controlled clinical trial

    American Journal of Respiratory and Critical Care Medicine, Vol. 201, Núm. 5, pp. 586-597

  3. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 4, pp. 359-367

  4. Intra- and Inter-Physician Agreement in Therapeutic Decision for Sleep Apnea Syndrome

    Archivos de Bronconeumologia, Vol. 56, Núm. 1, pp. 18-22

  5. Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial

    Chest, Vol. 158, Núm. 3, pp. 1176-1186

  6. The effect of sleep apnea on cardiovascular events in different acute coronary syndrome phenotypes

    American Journal of Respiratory and Critical Care Medicine, Vol. 202, Núm. 12, pp. 1698-1706

2019

  1. Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial

    The Lancet, Vol. 393, Núm. 10182, pp. 1721-1732

2018

  1. Cardiac Troponin Values in Patients With Acute Coronary Syndrome and Sleep Apnea: A Pilot Study

    Chest, Vol. 153, Núm. 2, pp. 329-338

  2. Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome

    Thorax, Vol. 73, Núm. 4, pp. 361-368

2016

  1. Mid- and Long-Term Efficacy of Non-Invasive Ventilation in Obesity Hypoventilation Syndrome: The Pickwick's Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 3, pp. 158-165

  2. Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea

    Thorax, Vol. 71, Núm. 10, pp. 899-906

  3. Protective Cardiovascular Effect of Sleep Apnea Severity in Obesity Hypoventilation Syndrome

    Chest, Vol. 150, Núm. 1, pp. 68-79

  4. The effect of supplemental oxygen in obesity hypoventilation syndrome

    Journal of Clinical Sleep Medicine, Vol. 12, Núm. 10, pp. 1379-1388